Cover Image
市場調查報告書

放射治療:技術及全球市場

Radiotherapy: Technologies and Global Markets

出版商 BCC Research 商品編碼 324688
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
放射治療:技術及全球市場 Radiotherapy: Technologies and Global Markets
出版日期: 2015年02月18日 內容資訊: 英文 130 Pages
簡介

放射治療市場,2013年達54億美元,2014年達58億美元的市場規模。該市場今後預計以6.7%的年複合成長率推移,2019年成長到81億美元的規模。

本報告提供全球放射治療市場現況與展望的相關調查、相關技術與用途概要、市場趨勢的分析與年複合成長率預測、核醫學主要的促進成長要素相關的議論、主要課題、診斷用途分析、主要企業的簡介等彙整。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 癌症的簡介
  • 放射線的簡介
  • 非電離放射線
  • 電離放射線
  • 粒子放射線
  • 放射線治療的歷史
  • 作用機制
  • 促進要素
  • 阻礙要素
  • 機會
  • 趨勢
  • 威脅
  • 市場佔有率分析
  • 各種各樣的癌症治療
  • 立體定位放射治療 (SRS) 及分割立體定位放射治療

第4章 放射治療市場:各產品

  • 體外放射治療
  • 作用機制
  • 線性加速器 (LINACS)
  • LINACS的類型:各技術
  • 粒子治療
  • 近距離放射治療
  • PDR 近距離放射治療
  • LDR 近距離放射治療
  • HDR 近距離放射治療
  • 電子近距離放射治療
  • 治療用放射性醫藥品:各類型
  • α發射體與β輻射體比較
  • 放射性核種的不足
  • 給藥途徑
  • 開發中產品

第5章 放射治療市場:各用途

  • 體外放射治療市場
  • 前列腺癌症
  • 乳癌
  • 肺癌症
  • 頭部、頸椎癌症
  • 其他癌症
  • 內照射療法市場:各用途
  • 前列腺癌症
  • 頭部、頸椎癌症
  • 婦產科癌症
  • 乳癌
  • 子宮頸癌症
  • 全身放射治療
  • 甲狀腺功能亢進症
  • 癌症細胞的骨骼轉移
  • 淋巴瘤
  • 內分泌腫瘤

第6章 放射治療市場:各地區

  • 美國
  • 歐洲
  • 亞洲
  • 日本
  • 中國
  • 印度
  • 其他 (ROW)
  • 南美
  • 中東
  • 非洲

第7章 企業簡介

  • ACCURAY INCORPORATED
  • ACTINIUM PHARMACEUTICALS INC.
  • AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION (ANSTO)
  • C. R. BARD INC.
  • ECKERT & ZIEGLER BEBIG S.A
  • ELEKTA
  • GE HEALTHCARE
  • IBA MOLECULAR
  • NORDION INC.
  • NTP RADIOISOTOPES (PTY) LTD.
  • SIEMENS HEALTHCARE
  • VARIAN MEDICAL SYSTEMS

第8章 附錄A:各癌症類型的致癌物質清單

第9章 附錄B:縮寫清單

圖表

目錄
Product Code: HLC176A

REPORT HIGHLIGHTS

The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in 2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%.

This report provides:

  • An overview of the global market for radiotherapy and related technologies and applications
  • Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019
  • Discussion of major factors driving the growth for nuclear medicine including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine
  • Detailed information conerning major challenges the market faces including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes
  • Analysis of the diagnostic applications for radiotherapy such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)
  • Comprehensive company profiles of major players in the industry.

SCOPE OF REPORT

This research report categorizes the radiation therapy market into three types of radiation therapy, which are External Beam radiation therapy, Internal Radiation therapy/Brachytherapy and Systemic Radiation therapy. External Radiotherapy is future divided into Gamma Knife, LINACS.( 3D-CRT, IMRT,IGRT), Proton Therapy System (Proton-based and Carbon-based). Internal Radiotherapy is divided into three types: Low dose Brachytherapy (Seeds: I-125, Pd-103, Applicators and Afterloaders), High dose brachytherapy (Seeds: Ir-192, Applicators and Afterloaders) and Electronic Brachytherapy. Systemic radiation therapy is bifurcated into two segments: Alpha emitter (Radium (Ra-233) and Beta emitters (Iodine (I-131), Rhenium (Re-186), Samarium (Sm-153), Yttrium-90 (Y-90), Lutetium-177 (LU-177).

Radiation therapy has also been studied based on the various applications into: External radiation therapy applications: Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer; Internal Radiation therapy applications: Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer; and Systemic Radiation therapy applications: Hyperthyroidism, Bone Metastasis, Lymphoma, Endocrine tumor. Also, the Radiation therapy market by geography: U.S., Europe, Asia, Rest of the World.

ANALYST'S CREDENTIALS

Neha Maliwal, a graduate in biotechnology and a postgraduate in marketing and biotechnology at the University of Pune (India), is the author of this study and numerous others, including the analyses of related markets such as antibiotics, radiopharmaceuticals, healthcare business process outsourcing (BPO) and biotechnology instrumentation.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • RESEARCH METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)

CHAPTER 3 - MARKET OVERVIEW

  • INTRODUCTION
  • INTRODUCTION TO CANCER
    • BENIGN TUMORS
    • MALIGNANT TUMORS
      • Malignant Tumor Categories
        • Carcinomas
        • Sarcomas
    • OTHER TYPES OF CANCER
      • TABLE 1: CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
    • CAUSES OF CANCER
      • Internal Factors
      • External Factors
    • CANCER PROTECTIVE FACTORS AND RISK FACTORS
      • TABLE 2: THE IMPACT OF CANCER PROTECTIVE FACTORS AND CANCER RISK FACTORS ON VARIOUS TYPES OF CANCERS
  • INTRODUCTION TO RADIATION
    • FIGURE 1: TYPES OF RADIATION
  • NON-IONIZING RADIATION
  • IONIZING RADIATION
  • PARTICLE RADIATION
    • Electron Beams
    • Proton Beams
    • Neutron Beams
    • Carbon Ions
    • Alpha and Beta Particles
    • Photon Radiations
    • Gamma Rays
    • X-rays
  • HISTORY OF RADIATION THERAPY
    • The Discovery Period
    • Megavoltage Era (1946-1996)
    • Computer-assisted ERA (1996-2013)
  • MECHANISM OF ACTION
    • CELL GROWTH CYCLE
      • FIGURE 2: CELL GROWTH CYCLE
      • TABLE 3: STEPS INVOLVED IN RADIATION THERAPY
    • RISK MANAGEMENT AND QUALITY ASSURANCE IN RADIATION THERAPY
    • RADIATION THERAPY MARKET SEGMENTATION
      • FIGURE 3: RADIATION THERAPY MARKET SEGMENTATION
    • DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS
      • FIGURE 4: DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS IN THE RADIATION THERAPY MARKET
  • DRIVERS
    • Increasing Incidences of Cancer
    • High Incidence of Cancer in Aging Population
      • FIGURE 5: GLOBAL AGING POPULATION (MILLIONS)
      • FIGURE 6: FACTORS RELATED TO AGING AND THE PROMOTION OF CANCER
    • High Efficiency of Radiotherapy
    • Palliative Radiation Therapy
    • Government Funding
    • Advancement in Technology
    • Reimbursement Boosting Market Growth
  • RESTRAINTS
    • Capital Intensive
    • Lack of Trained Professionals
    • Limited Effectiveness against Metastatic Cancer
    • Side Effects Associated with Radiation Therapy
  • OPPORTUNITY
    • Developing Countries
    • Personalized Treatment
  • TRENDS
    • VMAT
    • Proton Therapy
    • Carbon Ions
  • THREAT
    • Recession Can Restrict the Growth of Radiation Therapy Market
  • MARKET SHARE ANALYSIS
    • FIGURE 7: MARKET SHARE ANALYSIS OF THE RADIATION THERAPY MARKET, 2013 (%)
  • VARIOUS CANCER TREATMENTS
    • TABLE 4: ADVANTAGES AND DISADVANTAGES OF VARIOUS CANCER TREATMENTS
  • STEREOTACTIC RADIOSURGERY (SRS) AND FRACTIONATED STEREOTACTIC RADIATION THERAPY

CHAPTER 4 - RADIATION THERAPY MARKET BY PRODUCTS

  • TABLE 5: COMPARISON OF EXTERNAL BEAM RADIATION THERAPY AND BRACHYTHERAPY
  • EXTERNAL BEAM RADIATION THERAPY
    • TREATMENT PLANNING FOR EXTERNAL BEAM RADIATION
      • Dosing and Treatment with External Beam Radiation
        • TABLE 6: EXTERNAL BEAM RADIATION THERAPY MARKET BY TYPE THROUGH 2019 ($ MILLIONS)
        • TABLE 7: EXTERNAL BEAM RADIATION THERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
    • GAMMA KNIFE
  • MECHANISM OF ACTION
    • TABLE 8: GAMMA KNIFE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • LINEAR ACCELERATORS (LINACS)
    • Structure of Linear Accelerators
    • Electron Guns
    • The Buncher
    • The LINACS
    • Magnetrons
    • Klystrons
    • Beam Collimation and Monitoring
      • TABLE 9: ELECTRON EMITTING HIGH ENERGY LINEAR ACCELERATORS BY REGION, THROUGH 2019 ($ MILLIONS)
      • TABLE 10: LINACS MARKET BY TECHNIQUES, THROUGH 2019 ($ MILLIONS)
  • TYPES OF LINACS BY TECHNIQUES
    • Three-dimensional Conformal Radiation Therapy (3D-CRT)
      • TABLE 11: THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
    • Intensity-modulated Radiation Therapy (IMRT)
    • High Cost Restricts the Use
      • TABLE 12: INTENSITY-MODULATED RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • Image-guided Radiation Therapy (IGRT)
      • TABLE 13: IMAGE-GUIDED RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • Other LINACS
      • TABLE 14: OTHER LINACS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • PARTICLE THERAPY
    • TABLE 15: COMPARISON OF PROTON BEAM THERAPY AND CARBON ION THERAPY
    • TABLE 16: PARTICLE THERAPY SYSTEM BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: PARTICLE THERAPY SYSTEM MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 18: PROTON SYSTEMS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • Carbon Ions
      • TABLE 19: CARBON ION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • BRACHYTHERAPY
    • TABLE 20: COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
    • TABLE 21: ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
    • TABLE 22: VARIOUS TYPES OF BRACHYTHERAPY IMPLANTS
    • TABLE 23: BRACHYTHERAPY TREATMENT DURATION
    • TABLE 24: BRACHYTHERAPY TREATMENT DOSE RATE
    • TABLE 25: BRACHYTHERAPY TREATMENT SOURCE LOADING
  • PDR BRACHYTHERAPY
    • TABLE 26: COMPARISON OF LOW DOSE AND HIGH DOSE RADIATION THERAPY
    • TABLE 27: GLOBAL BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
    • TABLE 28: GLOBAL BRACHYTHERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • LDR BRACHYTHERAPY MARKET
    • TABLE 29: GLOBAL LDR BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
    • TABLE 30: GLOBAL LDR BRACHYTHERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • LDR Brachytherapy Seeds
      • TABLE 31: MARKET FOR LDR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
    • Brachytherapy Seeds Market by Type of Radioisotope
      • TABLE 32: GLOBAL BRACHYTHERAPY SEEDS MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • Iodine-125
      • TABLE 33: GLOBAL I-125 SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • Palladium-103
      • TABLE 34: GLOBAL PD-103 SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • Other Seeds
      • TABLE 35: GLOBAL OTHER LDR BRACHYTHERAPY SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • TABLE 36: LDR AFTERLOADER AND APPLICATOR MARKET BY GEOGRAPHY THROUGH 2019 ($ MILLIONS)
  • HDR BRACHYTHERAPY MARKET
    • TABLE 37: HDR BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
    • TABLE 38: HDR BRACHYTHERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • HDR Brachytherapy Seed Market
      • TABLE 39: HDR SEEDS MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
      • TABLE 40: HDR SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • Iridium-192 seeds
      • TABLE 41: IR-192 SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • Other HDR Seeds
      • TABLE 42: OTHER HDR SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • TABLE 43: HDR AFTERLOADER AND APPLICATOR MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • ELECTRONIC BRACHYTHERAPY
    • TABLE 44: COMPARISON BETWEEN RADIONUCLIDES AND ELECTRONIC BRACHYTHERAPY
    • TABLE 45: GLOBAL ELECTRONIC BRACHYTHERAPY MARKET BY GEOGRAPHY THROUGH 2019 ($ MILLIONS)
  • THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE
    • TABLE 46: ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
  • COMPARISON BETWEEN ALPHA AND BETA EMITTERS
    • TABLE 47: COMPARISON OF ALPHA AND BETA PARTICLES
  • SHORTAGE OF RADIONUCLIDES
    • CUMBERSOME REGULATORY REQUIREMENTS
      • TABLE 48: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
      • TABLE 49: SYSTEMIC RADIATION THERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
    • ALPHA EMITTERS
      • TABLE 50: GLOBAL ALPHA EMITTER MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
      • TABLE 51: GLOBAL ALPHA EMITTER MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • TABLE 52: EXAMPLES OF ALPHA EMITTERS
      • TABLE 53: ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
      • Radium-223
      • Mechanism of Action
    • BETA EMITTERS
      • TABLE 54: GLOBAL BETA EMITTERS MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
      • TABLE 55: ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
      • TABLE 56: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
      • Iodine-131
        • TABLE 57: GLOBAL IODINE-131 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • Rhenium (Re-186)
        • TABLE 58: GLOBAL RHENIUM-186 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • Samarium (Sm-153)
        • TABLE 59: GLOBAL SAMARIUM-153 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • Yttrium-90 (Y-90)
        • TABLE 60: GLOBAL YTTRIUM-90 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • Lutetium-177 (Lu-177)
        • TABLE 61: GLOBAL LUTETIUM-177 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • Others
        • TABLE 62: GLOBAL OTHER BETA EMITTERS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • ROUTE OF ADMINISTRATION
    • Introduction
      • Intravenous Administration
      • Inhalation Administration
      • Peroral Administration
      • Other Routes of Administration
        • TABLE 63: OTHER ROUTES OF ADMINISTRATION
  • PIPELINE PRODUCTS
    • TABLE 64: PIPELINE PRODUCTS IN RADIOPHARMACEUTICALS

CHAPTER 5 - RADIATION THERAPY MARKET BY APPLICATION

  • EXTERNAL BEAM RADIATION THERAPY MARKET
    • TABLE 65: EXTERNAL BEAM RADIATION THERAPY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • PROSTATE CANCER
    • Life Expectancy
    • Overall Health Status
    • Tumor Characteristics
      • Stage I Prostate Cancer
      • Stage II Prostate Cancer
      • Stage III Prostate Cancer
      • Stage IV Prostate Cancer
      • Personal Preferences
    • Advantages of EBRT in Treating Prostate Cancer
    • Side Effects
    • Disadvantages
  • BREAST CANCER
  • LUNG CANCER
    • Types of Lung Cancer
      • Non-Small Cell Lung Cancer
      • Small Cell Lung Cancer
      • Lung Carcinoid Tumor
  • HEAD AND NECK CANCER
    • Conformal Radiation Therapy (CRT)
  • OTHER CANCERS
  • INTERNAL RADIATION THERAPY MARKET BY APPLICATION
    • TABLE 66: INTERNAL BEAM RADIATION THERAPY BY APPLICATION THROUGH 2019 ($ MILLIONS)
  • PROSTATE CANCER
  • HEAD AND NECK CANCER
  • GYNECOLOGICAL CANCER
    • Vaginal Cancer
  • BREAST CANCER
  • CERVICAL CANCER
  • SYSTEMIC RADIATION THERAPY
    • TABLE 67: SYSTEMIC RADIATION THERAPY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • HYPERTHYROIDISM
  • BONE METASTASES
  • LYMPHOMA
  • ENDOCRINE TUMORS

CHAPTER 6 - RADIATION THERAPY MARKET BY GEOGRAPHY

  • UNITED STATES
    • TABLE 68: U.S. RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 69: U.S. INSTALLED BASE AND AGE
    • TABLE 70: NEW CANCER CASES AND ESTIMATED DEATHS IN THE YEAR 2014
    • TABLE 71: AGING U.S. POPULATION, 2000-2050
  • EUROPE
    • TABLE 72: EUROPEAN RADIATION THERAPY MARKET BY TYPE THROUGH 2019 ($ MILLIONS)
  • ASIA
    • TABLE 73: ASIAN RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
  • JAPAN
    • TABLE 74: COMPARISON OF INDIAN AND CHINESE RADIATION THERAPY MARKETS
  • CHINA
  • INDIA
  • REST OF THE WORLD
    • TABLE 75: REST OF THE WORLD RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
  • LATIN AMERICA
  • MIDDLE EAST
  • AFRICA

CHAPTER 7 - COMPANY PROFILES

  • ACCURAY INCORPORATED
    • FINANCIALS
      • TABLE 76: ACCURAY REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • PRODUCTS
      • TABLE 77: ACCURAY PRODUCTS
    • RECENT NEWS
      • TABLE 78: ACCURAY RECENT NEWS
  • ACTINIUM PHARMACEUTICALS INC.
  • AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION (ANSTO)
  • C. R. BARD INC.
    • FINANCIALS
      • TABLE 79: C.R. BARD REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS)
    • PRODUCTS
  • ECKERT & ZIEGLER BEBIG S.A
    • FINANCIALS
      • TABLE 80: ECKERT & ZIEGLER REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • PRODUCTS
    • RECENT NEWS
      • TABLE 81: ECKERT & ZIEGLER RECENT NEWS
  • ELEKTA
    • FINANCIALS
      • TABLE 82: ELEKTA REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • PRODUCTS
    • RECENT NEWS
      • TABLE 83: ELEKTA RECENT NEWS
  • GE HEALTHCARE
    • GE HEALTHCARE LIFE SCIENCES
    • PRODUCTS
  • IBA MOLECULAR
  • NORDION INC.
  • NTP RADIOISOTOPES (PTY) LTD.
  • SIEMENS HEALTHCARE
    • FINANCIALS
      • TABLE 84: SIEMENS REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • PRODUCTS
    • RECENT NEWS
      • TABLE 85: SIEMENS RECENT NEWS
  • VARIAN MEDICAL SYSTEMS
    • FINANCIALS
      • TABLE 86: VARIAN REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • PRODUCTS
    • RECENT NEWS
      • TABLE 87: VARIAN RECENT NEWS

CHAPTER 8 - APPENDIX A LIST OF HUMAN OF CARCINOGENIC AGENTS BY TYPE OF CANCER

  • TABLE 88: LIST OF CARCINOGENIC AGENTS

CHAPTER 9 - APPENDIX B LIST OF ACRONYMS

LIST OF TABLES

  • SUMMARY TABLE: RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
    • TABLE 2: THE IMPACT OF CANCER PROTECTIVE FACTORS AND CANCER RISK FACTORS ON VARIOUS TYPES OF CANCERS
    • TABLE 3: STEPS INVOLVED IN RADIATION THERAPY
    • TABLE 4: ADVANTAGES AND DISADVANTAGES OF VARIOUS CANCER TREATMENTS
    • TABLE 5: COMPARISON OF EXTERNAL BEAM RADIATION THERAPY AND BRACHYTHERAPY
    • TABLE 6: EXTERNAL BEAM RADIATION THERAPY MARKET BY TYPE THROUGH 2019 ($ MILLIONS)
    • TABLE 7: EXTERNAL BEAM RADIATION THERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 8: GAMMA KNIFE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 9: ELECTRON EMITTING HIGH ENERGY LINEAR ACCELERATORS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 10: LINACS MARKET BY TECHNIQUES, THROUGH 2019 ($ MILLIONS)
    • TABLE 11: THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 12: INTENSITY-MODULATED RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 13: IMAGE-GUIDED RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 14: OTHER LINACS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 15: COMPARISON OF PROTON BEAM THERAPY AND CARBON ION THERAPY
    • TABLE 16: PARTICLE THERAPY SYSTEM BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: PARTICLE THERAPY SYSTEM MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 18: PROTON SYSTEMS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 19: CARBON ION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 20: COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
    • TABLE 21: ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
    • TABLE 22: VARIOUS TYPES OF BRACHYTHERAPY IMPLANTS
    • TABLE 23: BRACHYTHERAPY TREATMENT DURATION
    • TABLE 24: BRACHYTHERAPY TREATMENT DOSE RATE
    • TABLE 25: BRACHYTHERAPY TREATMENT SOURCE LOADING
    • TABLE 26: COMPARISON OF LOW DOSE AND HIGH DOSE RADIATION THERAPY
    • TABLE 27: GLOBAL BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
    • TABLE 28: GLOBAL BRACHYTHERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 29: GLOBAL LDR BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
    • TABLE 30: GLOBAL LDR BRACHYTHERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 31: MARKET FOR LDR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 32: GLOBAL BRACHYTHERAPY SEEDS MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 33: GLOBAL I-125 SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 34: GLOBAL PD-103 SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 35: GLOBAL OTHER LDR BRACHYTHERAPY SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 36: LDR AFTERLOADER AND APPLICATOR MARKET BY GEOGRAPHY THROUGH 2019 ($ MILLIONS)
    • TABLE 37: HDR BRACHYTHERAPY MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
    • TABLE 38: HDR BRACHYTHERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 39: HDR SEEDS MARKET BY PRODUCT, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: HDR SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 41: IR-192 SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 42: OTHER HDR SEEDS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 43: HDR AFTERLOADER AND APPLICATOR MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 44: COMPARISON BETWEEN RADIONUCLIDES AND ELECTRONIC BRACHYTHERAPY
    • TABLE 45: GLOBAL ELECTRONIC BRACHYTHERAPY MARKET BY GEOGRAPHY THROUGH 2019 ($ MILLIONS)
    • TABLE 46: ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
    • TABLE 47: COMPARISON OF ALPHA AND BETA PARTICLES
    • TABLE 48: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 49: SYSTEMIC RADIATION THERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 50: GLOBAL ALPHA EMITTER MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 51: GLOBAL ALPHA EMITTER MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 52: EXAMPLES OF ALPHA EMITTERS
    • TABLE 53: ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
    • TABLE 54: GLOBAL BETA EMITTERS MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 55: ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
    • TABLE 56: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 57: GLOBAL IODINE-131 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 58: GLOBAL RHENIUM-186 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 59: GLOBAL SAMARIUM-153 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 60: GLOBAL YTTRIUM-90 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 61: GLOBAL LUTETIUM-177 MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 62: GLOBAL OTHER BETA EMITTERS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 63: OTHER ROUTES OF ADMINISTRATION
    • TABLE 64: PIPELINE PRODUCTS IN RADIOPHARMACEUTICALS
    • TABLE 65: EXTERNAL BEAM RADIATION THERAPY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 66: INTERNAL BEAM RADIATION THERAPY BY APPLICATION THROUGH 2019 ($ MILLIONS)
    • TABLE 67: SYSTEMIC RADIATION THERAPY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 68: U.S. RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 69: U.S. INSTALLED BASE AND AGE
    • TABLE 70: NEW CANCER CASES AND ESTIMATED DEATHS IN THE YEAR 2014
    • TABLE 71: AGING U.S. POPULATION, 2000-2050
    • TABLE 72: EUROPEAN RADIATION THERAPY MARKET BY TYPE THROUGH 2019 ($ MILLIONS)
    • TABLE 73: ASIAN RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 74: COMPARISON OF INDIAN AND CHINESE RADIATION THERAPY MARKETS
    • TABLE 75: REST OF THE WORLD RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 76: ACCURAY REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • TABLE 77: ACCURAY PRODUCTS
    • TABLE 78: ACCURAY RECENT NEWS
    • TABLE 79: C.R. BARD REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS)
    • TABLE 80: ECKERT & ZIEGLER REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • TABLE 81: ECKERT & ZIEGLER RECENT NEWS
    • TABLE 82: ELEKTA REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • TABLE 83: ELEKTA RECENT NEWS
    • TABLE 84: SIEMENS REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • TABLE 85: SIEMENS RECENT NEWS
    • TABLE 86: VARIAN REVENUES AND R &D EXPENDITURES, 2011-2013 ($ MILLIONS/%)
    • TABLE 87: VARIAN RECENT NEWS
    • TABLE 88: LIST OF CARCINOGENIC AGENTS

LIST OF FIGURES

  • SUMMARY FIGURE: RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 1: TYPES OF RADIATION
    • FIGURE 2: CELL GROWTH CYCLE
    • FIGURE 3: RADIATION THERAPY MARKET SEGMENTATION
    • FIGURE 4: DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS IN THE RADIATION THERAPY MARKET
    • FIGURE 5: GLOBAL AGING POPULATION (MILLIONS)
    • FIGURE 6: FACTORS RELATED TO AGING AND THE PROMOTION OF CANCER
    • FIGURE 7: MARKET SHARE ANALYSIS OF THE RADIATION THERAPY MARKET, 2013 (%)
Back to Top